COVID-19 Outbreak Impact on Anticoagulants Utilization: An Interrupted Time-Series Analysis Using Health Care Administrative Databases

Ippazio Cosimo Antonazzo; Carla Fornari; Olga Paoletti; Claudia Bartolini; Sara Conti; Paolo Angelo Cortesi; Lorenzo Giovanni Mantovani; Rosa Gini; Giampiero Mazzaglia

doi:10.1055/a-1523-7658

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2021; 121(08): 1115-1118
DOI: 10.1055/a-1523-7658

Letter to the Editor

COVID-19 Outbreak Impact on Anticoagulants Utilization: An Interrupted Time-Series Analysis Using Health Care Administrative Databases

Authors

Ippazio Cosimo Antonazzo

¹Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy
Carla Fornari

¹Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy
Olga Paoletti

²Osservatorio di Epidemiologia, Agenzia Regionale di Sanità della Toscana, Florence, Italy
Claudia Bartolini

²Osservatorio di Epidemiologia, Agenzia Regionale di Sanità della Toscana, Florence, Italy
Sara Conti

¹Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy

³Value-based Healthcare Unit, IRCCS MultiMedica, Sesto San Giovanni, Italy
Paolo Angelo Cortesi

¹Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy

³Value-based Healthcare Unit, IRCCS MultiMedica, Sesto San Giovanni, Italy
Lorenzo Giovanni Mantovani

¹Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy

³Value-based Healthcare Unit, IRCCS MultiMedica, Sesto San Giovanni, Italy
Rosa Gini

²Osservatorio di Epidemiologia, Agenzia Regionale di Sanità della Toscana, Florence, Italy
Giampiero Mazzaglia

¹Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy

Abstract

Full Text

References

References
1 Tartaglia N, Pavone G, Lizzi V. et al. How emergency surgery has changed during the COVID-19 pandemic: a cohort study. Ann Med Surg (Lond) 2020; 60 (60) 686-689
2 Farsalinos K, Poulas K, Kouretas D. et al. Improved strategies to counter the COVID-19 pandemic: lockdowns vs. primary and community healthcare. Toxicol Rep 2021; 8: 1-9
3 European Society of Cardiology-ESC. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Accessed January 28, 2021 at: https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance
4 Kiss P, Carcel C, Hockham C, Peters SAE. The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review. Eur Heart J Qual Care Clin Outcomes 2020; 5: 84
5 Holt A, Gislason GH, Schou M. et al. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J 2020; 41 (32) 3072-3079
6 Andersson C, Gerds T, Fosbøl E. et al. Incidence of new-onset and worsening heart failure before and after the COVID-19 epidemic lockdown in Denmark: a nationwide cohort study. Circ Heart Fail 2020; 13 (06) e007274
7 Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002; 27 (04) 299-309
8 Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol 2017; 46 (01) 348-355
9 Boriani G, Palmisano P, Guerra F. et al; AIAC Ricerca Network Investigators. Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing). Intern Emerg Med 2020; 15 (08) 1445-1456
10 Negreira Caamano M, Piqueras Flores J, Mateo Gomez C. Impact of COVID-19 pandemic in cardiology admissions. Med Clin (Barc) 2020; 155: 179-180
11 Garcia S, Albaghdadi MS, Meraj PM. et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol 2020; 75 (22) 2871-2872
12 Toniolo M, Negri F, Antonutti M, Masè M, Facchin D. Unpredictable fall of severe emergent cardiovascular diseases hospital admissions during the COVID-19 pandemic: experience of a single large center in Northern Italy. J Am Heart Assoc 2020; 9 (13) e017122
13 Wu Y, Chen F, Wang Z. et al. Reductions in hospital admissions and delays in acute stroke care during the pandemic of COVID-19. Front Neurol 2020; 11: 584734
14 Holt A, Gislason GH, Schou M. et al. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J 2020; 41 (32) 3072-3079
15 Poli D, Tosetto A, Palareti G. et al; On the behalf of Italian Federation of Anticoagulation Clinics (FCSA). Managing anticoagulation in the COVID-19 era between lockdown and reopening phases. Intern Emerg Med 2020; 15 (05) 783-786
16 England NHS, Improvement NHS. Clinical Guide for the Management of Anticoagulant Services During the Coronavirus Pandemic, 2020. Accessed February 1, 2021 at: https://www.nice.org.uk/Media/Default/About/COVID-19/Specialty-guides/specialty-guide-anticoagulant-services-and-coronavirus.pdf
17 D'Ascenzi F, Cameli M, Forni S. et al. Reduction of emergency calls and hospitalizations for cardiac causes: effects of Covid-19 pandemic and lockdown in Tuscany region. Front Cardiovasc Med 2021; 8: 625569